Products - HIV and AIDS | Topic | NICE

Showing 9 products

Date | Title

Status: Topic selectionRemove ‘Status: Topic selection’ filter

Darunavir plus cobicistat fixed dose combination for paediatric human immunodeficiency virus 1 infection [TSID10722]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Emtricitabine/tenofovir alafenamide for human immunodeficiency virus type-1 infection [TSID10723]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Lenacapavir for treating multidrug resistant HIV-1 [ID6196]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Spinal Cord Stimulation Effective for HIV Neuropathy
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Doravirine-islatravir for previously untreated HIV-1 infection [TSID12172]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Doravirine–islatravir for treating HIV-1 in people with virological suppression on bictegravir, emtricitabine and tenofovir alafenamide combination treatment [TSID12171]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Doravirine–islatravir for treating HIV-1 in people with virological suppression on antiretroviral therapy [TSID12173]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Oral cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12214]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Long-acting injections of cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12219]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC